MedX Health Corp. (V:MDX*CA)

Business Focus: Advanced Medical Equipment & Technology (NEC)

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
Company Contact
Address: 1495 Bonhill Road, Unit # 1 Mississauga
MISSISSAUGA ON L5T 1M2
Tel: N/A
Website: https://medxhealth.com
IR: See website
<
Key People
Stephen Lockyer
Acting Chief Executive Officer, Director
Christopher H. Freeman
Acting Chief Financial Officer, Corporate Secretary
Michael Druhan
President - Dermatological Services and Products
Business Overview
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
Financial Overview
For the fiscal year ended 31 December 2023, Medx Health Corp revenues decreased 11% to C$456K. Net loss decreased 11% to C$4.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Salaries and benefits, contractors decrease of 51% to C$587K (expense), Sales and market development decrease of 70% to C$233K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $29.17M as of Dec 31, 2023
Annual revenue (TTM): $0.46M as of Dec 31, 2023
EBITDA (TTM): -$2.97M as of Dec 31, 2023
Net annual income (TTM): -$4.58M as of Dec 31, 2023
Free cash flow (TTM): -$3.42M as of Dec 31, 2023
Net Debt Last Fiscal Year: $5.71M as of Dec 31, 2023
Shares outstanding: 261,956,603 as of Feb 9, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.